HempNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Engagement of Stadnyk & Partners
Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced its entry into an agreement with Stadnyk & Partners whereby PreveCeutical will engage Stadnyk & Partners to provide market awareness and strategic advisory services to the company. Per the terms of the agreement, Stadnyk & Partners will provide market awareness services to the company throughout the initial 12-month term of the agreement in exchange for two million stock options, each of which will be exercisable to acquire one common share in the capital of PreveCeutical for $0.08 per share for a period of 24 months.…